John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Alaunos Therapeutics
TCRT
$4.55M
| $1.16M | ﹤0.01% |
11,884
-5,651
| -32% | -$725K |
|
1627
Amerant Bancorp
AMTB
$1.12B
| $1.16M | ﹤0.01% |
36,782
+19,239
| +110% | +$637K |
|
|
TGA
1628
DELISTED
Transglobe Energy Corp
TGA
| $1.16M | ﹤0.01% |
318,971
+304,142
| +2,051% | +$1.03M |
|
1629
Lakeland Financial Corp
LKFN
$1.48B
| $1.16M | ﹤0.01% |
15,857
+2,007
| +14% | +$160K |
|
1630
Cardiff Oncology
CRDF
$78.6M
| $1.16M | ﹤0.01% |
466,347
+88,978
| +24% | +$315K |
|
1631
InterContinental Hotels
IHG
$24.2B
| $1.16M | ﹤0.01% |
+16,796
| New | +$1.14M |
|
1632
First Industrial Realty Trust
FR
$8.4B
| $1.16M | ﹤0.01% |
18,658
-189,491
| -91% | -$11.3M |
|
|
RJET
1633
Republic Airways Holdings
RJET
$897M
| $1.15M | ﹤0.01% |
17,434
+6,791
| +64% | +$487K |
|
1634
Kforce
KFRC
$1.03B
| $1.14M | ﹤0.01% |
15,447
-2,639
| -15% | -$188K |
|
1635
Runway Growth Finance
RWAY
$275M
| $1.14M | ﹤0.01% |
83,997
-6,908
| -8% | -$91.4K |
|
|
TRST
1636
Trustco Bank Corp NY
TRST
$969M
| $1.14M | ﹤0.01% |
35,657
-16,998
| -32% | -$575K |
|
1637
Cass Information Systems
CASS
$732M
| $1.14M | ﹤0.01% |
30,741
-4,256
| -12% | -$170K |
|
|
MANT
1638
DELISTED
Mantech International Corp
MANT
| $1.14M | ﹤0.01% |
+13,166
| New | +$1.05M |
|
1639
Mercantile Bank Corp
MBWM
$1.04B
| $1.13M | ﹤0.01% |
31,982
+10,753
| +51% | +$402K |
|
1640
Black Diamond Therapeutics
BDTX
$128M
| $1.13M | ﹤0.01% |
407,423
+106,421
| +35% | +$389K |
|
1641
Unitil
UTL
$982M
| $1.13M | ﹤0.01% |
22,565
-1,800
| -7% | -$88K |
|
1642
York Water
YORW
$556M
| $1.13M | ﹤0.01% |
25,046
+6,949
| +38% | +$310K |
|
1643
Kanzhun
BZ
$7.29B
| $1.13M | ﹤0.01% |
+45,161
| New | +$1.31M |
|
|
RYZ
1644
Ryerson Holding Corp
RYZ
$1.28B
| $1.13M | ﹤0.01% |
+32,119
| New | +$874K |
|
1645
MBIA
MBI
$251M
| $1.12M | ﹤0.01% |
73,016
-13,067
| -15% | -$192K |
|
1646
Franklin Covey
FC
$230M
| $1.12M | ﹤0.01% |
24,776
-13,039
| -34% | -$604K |
|
|
ORGN
1647
DELISTED
Origin Materials
ORGN
| $1.11M | ﹤0.01% |
5,639
+4,206
| +294% | +$733K |
|
|
KNBE
1648
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $1.11M | ﹤0.01% |
+48,300
| New | +$1.04M |
|
1649
Gates Industrial Corp
GTES
$6.57B
| $1.11M | ﹤0.01% |
73,700
-181,040
| -71% | -$2.83M |
|
1650
Fulton Financial
FULT
$4.52B
| $1.11M | ﹤0.01% |
66,659
-10,941
| -14% | -$196K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.